bioRxivPharmacology & ToxicologyPreprint
Cinnamaldehyde interacts with the local anesthetic pocket of the NaV 1.5 channel
Julio Alvarez‐CollazoiD, Alejandro López‐RequenaiD, Ariel Talavera, Julio L. ÁlvareziD, Karel TalaveraiD
Abstract
Cinnamaldehyde (CA) is extensively used as flavorant and in traditional medicine. CA is com-monly used in pain research as specific agonist of TRPA1, a polymodal cation channel expressed in nociceptive primary sensory neurons. However, we previously showed that CA inhibits the L-type Ca2+ channel in cardiac and smooth muscle cells, raising the possibility that other ion channels can be modulated by this compound as well. Here, we investigated whether CA exhibits affects the activity on the cardiac NaV1.5 channel. We used the whole-cell patch-clamp technique to record Na+ currents in HEK293T cells expressing the human NaV1.5 channel, as well as in cells expressing hNaV1.5 channels baring mutation in the binding pocket of local anesthetics (LA). Our results show that CA exhibit LA-like actions on hNaV1.5 channels: CA blocks hNaV1.5 currents in a tonic and voltage-dependent fashion. Residues F1760 and Y1767 are important for the blockade of NaV1.5 by CA and a double point mutation F1760A/Y1767A abolishes the blockade of INa by CA. We conclude that CA and LID share common structural determinants for the inhibition of Na+ channels and that CA has LA-like actions.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Capsaicin alters human NaV1.5 mechanosensitivity
L. M. Cowan, P. R. Strege, … G. Farrugia·bioRxiv·Jul 13, 2021
- Discovery of a Selective, State-Independent Inhibitor of NaV1.7 by Modification of Guanidinium Toxins
Hassan Pajouhesh, Jacob T. Beckley, … John V. Mulcahy·Scientific ReportsPeer-reviewed·Sep 9, 2020
- Cannabidiol Interactions with Voltage-Gated Sodium Channels
L. G. Sait, A. Sula, … B. A. Wallace·bioRxiv·Jun 15, 2020
- Targeting the CaV - interaction yields a selective antagonist of the N-type CaV2.2 channel with broad antinociceptive efficacy
Rajesh Khanna, Jie Yu, … May Khanna·PainPeer-reviewed·Feb 5, 2019
- Identification and targeting of a unique NaV1.7 domain driving chronic pain
Kimberly Gómez, Harrison J. Stratton, … Rajesh Khanna·Proceedings of the National Academy of SciencesPeer-reviewed·Jul 27, 2023
- Targeted ubiquitination of NaV1.8 reduces sensory neuronal excitability
Sidharth Tyagi, Mohammad‐Reza Ghovanloo, … Sulayman D. Dib‐Hajj·bioRxiv·Feb 4, 2025